( March 12, 2025, 1:30 PM EDT) -- FORT WORTH, Texas — Companies representing the interests of drug compounders appealed to the Fifth Circuit U.S. Court of Appeals a Texas federal judge’s ruling that denied a preliminary injunction and stay on the U.S. Food and Drug Administration’s decision to remove an FDA-approved drug for diabetes and weight loss from the agency’s drug shortage list....